Package 0615-8414-39

{"route": ["ORAL"], "spl_id": "d1aae137-9f68-4944-bcf4-c84bad592724", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "unii": ["R16CO5Y76E"], "rxcui": ["308416"], "spl_set_id": ["ed9a71d6-a56e-416a-bb89-6d41307efc5a"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "15 TABLET, COATED in 1 BLISTER PACK (0615-8414-05)", "package_ndc": "0615-8414-05", "marketing_end_date": "20261031", "marketing_start_date": "20230810"}, {"sample": false, "description": "30 TABLET, COATED in 1 BLISTER PACK (0615-8414-39)", "package_ndc": "0615-8414-39", "marketing_end_date": "20261031", "marketing_start_date": "20211103"}], "brand_name": "LOW DOSE ASPIRIN", "product_id": "0615-8414_d1aae137-9f68-4944-bcf4-c84bad592724", "dosage_form": "TABLET, COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "0615-8414", "generic_name": "ASPIRIN", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN OTC DRUG", "brand_name_base": "LOW DOSE ASPIRIN", "active_ingredients": [{"name": "ASPIRIN", "strength": "81 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_end_date": "20261031", "marketing_start_date": "20150619"}